Skip to main content
. 2011 Mar 10;43(3):675–680. doi: 10.1007/s11255-011-9912-2

Table 2.

Clinicopathologic characteristics of renal transplant recipients with RCC

Patient number Tumor location Tumor size (cm) Type Stage, Fuhrman Follow-up (month) Treatment
1 RK 2 Clear cell T1N0M0, G2 85 (Died) Lap nephrectomy
2 LK 5 Clear cell T1N0M0, G1 32 (Alive) Open nephrectomy
3 LK 2.3 Clear cell T1aN0M0, G2 25 (Alive) Open nephrectomy
4 RK 6 Papillary T1N0M0, G2 119 (Alive) Open nephrectomy
LK 1.5 Papillary T1N0M0, G2 Open nephrectomy
5 LK 4 Papillary T1N0M0, G1 68 (Alive) Open nephrectomy
6 RK 1.7 Clear cell T1N0M0, G2 45 (Alive) Open nephrectomy
7 LK 3 Clear cell T1N0M0, G2 21 (Alive) Open nephrectomy
8 RK 5.9 Papillary T1N0M0, G2 18 (Alive) Open nephrectomy
9 LK 4 Papillary T1N0M0, G1 73 (Alive) Open nephrectomy
10 LK 2.5 Papillary T2N1M0, G3 12 (Died) Open nephrectomy
11 RK 1 Clear cell T1N0M0, G2 50 (Alive) Open nephrectomy
12 RK 3.2 Clear cell T2N0M0, G3 4 (Alive) Lap nephrectomy

LK left kidney, RK right kidney, Lap laparoscopic